Colorado payers launch data-sharing tool

Laura Pedulli | | Health Exec | Economics

 

Seven health payers in Colorado are joining forces to develop a multi-payer data sharing online tool to improve healthcare delivery in the state.

Under the arrangement, the payers are creating a data solution that allows care providers to access their patients’ claims data from one website. Anthem Blue Cross and Blue Shield, Cigna, Colorado Access, Colorado Choice Health Plans, Colorado Medicaid/Colorado Department of Health Care Policy and Financing, Rocky Mountain Health Plans and United Healthcare are all participating in the endeavor.

“This initiative represents a major step forward for both providers and payers in the state. For the first time, physicians will be able to access actionable, patient-specific data across multiple insurers and self-funding employers in a single analytic tool,”said Patrick Gordon, associate vice president at Rocky Mountain Health Plans, in a statement. 

Laura Pedulli

Related Content

Merck spends up to $2B to license new weight loss drug with potential heart benefits
Insulet wins $452M in lawsuit against rivals over medical device trade secrets
Medical device company cuts 70% of staff in push to meet Medtronic obligations
Cleerly’s momentum continues as AI specialists raise $106M
Operations manager, doctors charged in $70M imaging kickback scheme
Private-equity watchdog warns against nominating Marc Rowan as Treasury Secretary

Around the web

Cardiovascular Business
FDA says years-long tirzepatide shortage is resolved, will give limited leeway to compounders

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

AI in Healthcare
From Capitol Hill to a hospital near you? 5 federal recommendations for healthcare AI policy

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Cardiovascular Business
Merck spends up to $2B to license new weight loss drug with potential heart benefits

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.